Literature DB >> 22284679

Regulation of KLF4 turnover reveals an unexpected tissue-specific role of pVHL in tumorigenesis.

Armin M Gamper1, Xinxian Qiao, Jennifer Kim, Liyong Zhang, Michelle C DeSimone, W Kimryn Rathmell, Yong Wan.   

Abstract

The transcription factor Krüppel-like factor 4 (KLF4) is an important regulator of cell-fate decision, including cell-cycle regulation, apoptosis, and stem cell renewal, and plays an ambivalent role in tumorigenesis as a tissue-specific tumor suppressor or oncogene. Here, we report that the Von Hippel-Lindau gene product, pVHL, physically interacts with KLF4 and regulates its rapid turnover observed in both differentiated and stem cells. We provide mechanistic insights into KLF4 degradation and show that pVHL depletion in colorectal cancer cells leads to cell-cycle arrest concomitant with increased transcription of the KLF4-dependent p21 gene. Finally, immunohistochemical staining revealed elevated pVHL and reduced KLF4 levels in colon cancer tissues. We therefore propose that unexpectedly pVHL, via the degradation of KLF4, is a facilitating factor in colorectal tumorigenesis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22284679      PMCID: PMC3982234          DOI: 10.1016/j.molcel.2011.11.031

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  26 in total

Review 1.  KLF4, p21 and context-dependent opposing forces in cancer.

Authors:  Benjamin D Rowland; Daniel S Peeper
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

2.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

3.  Destabilization of Krüppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway.

Authors:  Zhi Yi Chen; Xuesheng Wang; Yunhong Zhou; Gwynneth Offner; Chi-Chuan Tseng
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

4.  Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach.

Authors:  Jonathan P Katz; Nathalie Perreault; Bree G Goldstein; Lori Actman; Sara R McNally; Debra G Silberg; Emma E Furth; Klaus H Kaestner
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

5.  Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis.

Authors:  R H Giles; M P Lolkema; C M Snijckers; M Belderbos; P van der Groep; D A Mans; M van Beest; M van Noort; R Goldschmeding; P J van Diest; H Clevers; E E Voest
Journal:  Oncogene       Date:  2006-05-18       Impact factor: 9.867

6.  Decreased growth of Vhl-/- fibrosarcomas is associated with elevated levels of cyclin kinase inhibitors p21 and p27.

Authors:  Fiona A Mack; Jagruti H Patel; Mangatt P Biju; Volker H Haase; M Celeste Simon
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

7.  In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations.

Authors:  W Kimryn Rathmell; Michele M Hickey; Natalie A Bezman; Christie A Chmielecki; Natalie C Carraway; M Celeste Simon
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

8.  VHL loss causes spindle misorientation and chromosome instability.

Authors:  Claudio R Thoma; Alberto Toso; Katrin L Gutbrodt; Sabina P Reggi; Ian J Frew; Peter Schraml; Alexander Hergovich; Holger Moch; Patrick Meraldi; Wilhelm Krek
Journal:  Nat Cell Biol       Date:  2009-07-20       Impact factor: 28.824

9.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

10.  Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.

Authors:  C E Stebbins; W G Kaelin; N P Pavletich
Journal:  Science       Date:  1999-04-16       Impact factor: 47.728

View more
  41 in total

1.  C/EBP-Homologous Protein (CHOP) in Vascular Smooth Muscle Cells Regulates Their Proliferation in Aortic Explants and Atherosclerotic Lesions.

Authors:  Alex-Xianghua Zhou; Xiaobo Wang; Chyuan Sheng Lin; Jaeseok Han; Jing Yong; Marissa J Nadolski; Jan Borén; Randal J Kaufman; Ira Tabas
Journal:  Circ Res       Date:  2015-04-14       Impact factor: 17.367

Review 2.  Krüppel-like factors in cancer.

Authors:  Marie-Pier Tetreault; Yizeng Yang; Jonathan P Katz
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

3.  FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.

Authors:  H Zhou; Y Liu; R Zhu; F Ding; Y Wan; Y Li; Z Liu
Journal:  Oncogene       Date:  2017-01-09       Impact factor: 9.867

4.  Genome-wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer with VHL Loss.

Authors:  Xijuan Liu; Jeremy M Simon; Haibiao Xie; Lianxin Hu; Jun Wang; Giada Zurlo; Cheng Fan; Travis S Ptacek; Laura Herring; Xianming Tan; Mingjie Li; Albert S Baldwin; William Y Kim; Tao Wu; Marc W Kirschner; Kan Gong; Qing Zhang
Journal:  Mol Cell       Date:  2020-02-04       Impact factor: 17.970

Review 5.  DNA damage response and repair pathway modulation by non-histone protein methylation: implications in neurodegeneration.

Authors:  Madhusoodanan Urulangodi; Abhishek Mohanty
Journal:  J Cell Commun Signal       Date:  2019-11-20       Impact factor: 5.782

6.  Transcriptional landscape of the human cell cycle.

Authors:  Yin Liu; Sujun Chen; Su Wang; Fraser Soares; Martin Fischer; Feilong Meng; Zhou Du; Charles Lin; Clifford Meyer; James A DeCaprio; Myles Brown; X Shirley Liu; Housheng Hansen He
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-13       Impact factor: 11.205

7.  Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria.

Authors:  Kaori Hayashi; Hiroyuki Sasamura; Mari Nakamura; Yusuke Sakamaki; Tatsuhiko Azegami; Hideyo Oguchi; Hirobumi Tokuyama; Shu Wakino; Koichi Hayashi; Hiroshi Itoh
Journal:  Kidney Int       Date:  2015-06-24       Impact factor: 10.612

8.  Forkhead Transcription Factor 3a (FOXO3a) Modulates Hypoxia Signaling via Up-regulation of the von Hippel-Lindau Gene (VHL).

Authors:  Xing Liu; Xiaolian Cai; Bo Hu; Zhichao Mei; Dawei Zhang; Gang Ouyang; Jing Wang; Wei Zhang; Wuhan Xiao
Journal:  J Biol Chem       Date:  2016-10-24       Impact factor: 5.157

Review 9.  Deubiquitinases (DUBs) and DUB inhibitors: a patent review.

Authors:  Pershang Farshi; Rahul R Deshmukh; Joseph O Nwankwo; Richard T Arkwright; Boris Cvek; Jinbao Liu; Q Ping Dou
Journal:  Expert Opin Ther Pat       Date:  2015-06-16       Impact factor: 6.674

10.  The von hippel-lindau protein suppresses androgen receptor activity.

Authors:  Jing Wang; Wei Zhang; Wei Ji; Xing Liu; Gang Ouyang; Wuhan Xiao
Journal:  Mol Endocrinol       Date:  2014-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.